-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn’s disease (CD) is a chronic disabling inflammatory bowel disease (IBD).
Approximately half of patients require surgery in the first ten years after diagnosis, and one-third of patients require multiple procedures during the course of the disease.
Bowel resection surgery
.
The Rutgeerts score can classify the severity of CD recurrence symptoms under endoscopic surgery after ileocecal resection, so as to judge the disease recurrence under endoscopic surgery
Crohn’s disease (CD) is a chronic disabling inflammatory bowel disease (IBD).
Researchers conducted a retrospective study in 3 inflammatory bowel disease (IBD) centers in France and Belgium.
The trial was conducted from 2006 to 2016, and all CD patients (n=86) received a response.
For blind resection, there was no endoscopic evidence of disease recurrence at baseline assessment (Rutgeerts score lower than i2)
.
Postoperative recurrence after baseline endoscopy was defined as at least one of the following: clinical recurrence, IBD-related hospitalization, intestinal injury, the need for endoscopic balloon dilatation anastomoses, and the need for repeated surgical treatment
The median time between surgery and baseline endoscopy was 7 months (IQR, 5.
7-9.
5 months); 40 patients (46.
5%) received drug prophylaxis during this period
.
Thirty-five patients (40.
prevention
Figure: Endoscopic remission of Crohn's disease in patients with late recurrence after ileocecal resection
This study found that among CD patients treated by ileocecal resection, 40% of patients had late recurrence after a median follow-up time of 3.
5 years.
Although the initial endoscopic remission was achieved, it is still recommended after 18 months These patients are closely monitored for disease activity
.
5 years.
Although the initial endoscopic remission was achieved, it is still recommended after 18 months These patients are closely monitored for disease activity
.
Original source:
Lieven Pouillon.
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers.
Leave a message here